Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Identification of those at risk for diabetes mellitus can comparative effectiveness research provide the answer?

Geba D, Pearson TA.

Am J Prev Med. 2011 Jan;40(1):101-3. doi: 10.1016/j.amepre.2010.10.011. No abstract available.

PMID:
21146774
2.

[Screening for type 2 diabetes and impaired glucose tolerance].

Hirata A, Tominaga M.

Nihon Rinsho. 2005 Feb;63 Suppl 2:366-71. Review. Japanese. No abstract available.

PMID:
15779405
3.

Glycemic control and cardiovascular diseases in Type 2 diabetes mellitus. Beyond fasting glycemia and glycosylated hemoglobin.

Muggeo M, Bolli G, Bompiani G, Brunetti P, Capani F, Cavallo-Perin P, Comaschi M, Cordera R, Crepaldi G, Cucinotta D, Di Mario U, Fedele D, Ferrannini E, Giorgino R, Giugliano D, Gnudi A, Mancini M, Menzinger G, Pagano G, Pontiroli AE, Pozza G, Santeusanio F, Tiengo BA, Trovati M, Vigneri R.

Diabetes Nutr Metab. 2000 Aug;13(4):182-5. Review. No abstract available.

PMID:
10961484
4.

Tests of glycemia for the diagnosis of type 2 diabetes mellitus.

Barr RG, Nathan DM, Meigs JB, Singer DE.

Ann Intern Med. 2002 Aug 20;137(4):263-72. Review.

PMID:
12186517
5.

Glycemic response and health--a systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes.

Livesey G, Taylor R, Hulshof T, Howlett J.

Am J Clin Nutr. 2008 Jan;87(1):258S-268S. Review.

PMID:
18175766
6.

Postprandial hyperglycemia and cardiovascular disease.

Gerich JE.

Endocr Pract. 2006 Jan-Feb;12 Suppl 1:47-51. Review.

PMID:
16627380
7.

Impaired fasting glucose as a treatment target in diabetes management.

Oliveros RA, Zion AS, Rosenberg Y, Selvaraj CL, Chilton R.

Curr Cardiol Rep. 2009 Nov;11(6):460-7. Review.

PMID:
19863871
8.

Glucose control and cardiovascular outcomes in individuals with diabetes mellitus: lessons learned from the megatrials.

Avitabile NA, Banka A, Fonseca VA.

Heart Fail Clin. 2012 Oct;8(4):513-22. doi: 10.1016/j.hfc.2012.06.009. Epub 2012 Aug 11. Review.

PMID:
22999236
9.

Type 2 diabetes in children and adolescents.

Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ.

Pediatr Diabetes. 2009 Sep;10 Suppl 12:17-32. doi: 10.1111/j.1399-5448.2009.00584.x. Review. No abstract available.

PMID:
19754615
10.

Impact of pre-diabetes and diabetes on cardiovascular outcomes.

Anselmino M, Sillano D.

Curr Vasc Pharmacol. 2012 Nov;10(6):680-3. Review.

PMID:
23259552
11.

Diagnosing diabetes: blood glucose and the role of the laboratory.

Higgins C.

Br J Nurs. 2001 Feb 22-Mar 7;10(4):230-6. Review.

PMID:
12170647
12.

Screening for type 2 diabetes: a short report for the National Screening Committee.

Waugh NR, Shyangdan D, Taylor-Phillips S, Suri G, Hall B.

Health Technol Assess. 2013 Aug;17(35):1-90. doi: 10.3310/hta17350. Review.

13.

[An approach to the prevention of type 2 diabetes in industrial healthcare].

Sumida Y.

Nihon Rinsho. 2005 Feb;63 Suppl 2:588-96. Review. Japanese. No abstract available.

PMID:
15779445
14.

Screening for type 2 diabetes.

Engelgau MM, Narayan KM, Herman WH.

Diabetes Care. 2000 Oct;23(10):1563-80. Review. Erratum in: Diabetes Care 2000 Dec;23(12):1868-9.

15.

Impaired glucose tolerance, diabetes, and cardiovascular disease.

Schnell O, Standl E.

Endocr Pract. 2006 Jan-Feb;12 Suppl 1:16-9. Review.

PMID:
16627374
16.

The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.

Sattar NA, Ginsberg H, Ray K, Chapman MJ, Arca M, Averna M, Betteridge DJ, Bhatnagar D, Bilianou E, Carmena R, Ceška R, Corsini A, Erbel R, Flynn PD, Garcia-Moll X, Gumprecht J, Ishibashi S, Jambart S, Kastelein JJ, Maher V, da Silva PM, Masana L, Odawara M, Pedersen TR, Rotella CM, Salti I, Teramoto T, Tokgozoglu L, Toth PP, Valensi P, Vergès B.

Atheroscler Suppl. 2014 Jun;15(1):1-15. doi: 10.1016/j.atherosclerosissup.2014.04.001. Review.

PMID:
24840509
17.

Glucagon-like peptide-1 receptor agonists for diabetes mellitus: a role in cardiovascular disease.

Smilowitz NR, Donnino R, Schwartzbard A.

Circulation. 2014 Jun 3;129(22):2305-12. doi: 10.1161/CIRCULATIONAHA.113.006985. Review. No abstract available.

18.
19.

[IFG and IGT in Europe and America: the present and prospective].

Tsujii S, Kuzuya H.

Nihon Rinsho. 2005 Feb;63 Suppl 2:27-33. Review. Japanese. No abstract available.

PMID:
15779341
20.

[Hyperglycemia and cardiovascular risk].

Bianchi C, Del Prato S, Miccoli R.

G Ital Cardiol (Rome). 2010 Sep;11(9):654-9. Review. Italian.

PMID:
21348180

Supplemental Content

Support Center